On Air Now

Upcoming Shows

Program Schedule »

Tune in to Listen

650 AM Hibbing, Minnesota

Weather

Current Conditions(Hibbing,MN 55746)

More Weather »
44° Feels Like: 44°
Wind: NNW 3 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Partly Cloudy 42°

Tomorrow

Partly Cloudy 62°

Thurs Night

Partly Cloudy 34°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

Merck and Endocyte's ovarian cancer drug fails in trial

(Reuters) - Merck & Co Inc and Endocyte Inc said they had stopped a late-stage trial of their experimental ovarian cancer drug because it did not improve survival rates without the cancer worsening.

The trial was testing the drug, vintafolide, in combination with a chemotherapy drug, pegylated liposomal doxorubicin (PLD), compared to PLD plus a placebo.

An independent safety committee reviewing the trial had recommended that it be halted, the companies said in separate statements.

(Reporting by Esha Dey in Bangalore; Editing by Maju Samuel)

Comments